Wave Life Sciences Ltd. (WVE)

Finanzdaten der Wave Life Sciences Ltd.-Aktie (WVE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	40.96% 29.06	49.21	22.11	12.93	1.239
Operating Expenses	6.63% 47.74	44.77	45.58	43.21	44.80
Benefits Costs and Expenses	6.27% 45.31	42.64	43.21	40.33	44.27
Costs And Expenses	6.27% 45.31	42.64	43.21	40.33	44.27
Operating Income/Loss	520.39% -18.68	4.444	-23.47	-30.29	-43.56
Nonoperating Income/Loss	13.84% 2.426	2.131	2.369	2.88	0.535
Income/Loss From Continuing Operations Before Tax	347.24% -16.26	6.575	-21.10	-27.41	-43.03
Income Tax Expense/Benefit	100.00% -	-0.677	-	-	0.681
Income/Loss From Continuing Operations After Tax	324.16% -16.26	7.252	-21.10	-27.41	-43.71
Net Income/Loss	324.16% -16.26	7.252	-21.10	-27.41	-43.71
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.52% 1.568	106.03	105.46	102.06	5.1014
Diluted Average Shares	98.53% 1.568	106.98	105.46	102.06	5.1014
Basic Earnings Per Share	314.29% -0.15	0.07	-0.20	-0.27	-0.45
Diluted Earnings Per Share	314.29% -0.15	0.07	-0.20	-0.27	-0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	100.00% -	-0.257	-	-	-